Kalkine has a fully transformed New Avatar.

Mid-Cap

Are you an investor looking for mid-capitalization with sound fundamentals, earnings potential and possibly dividend paying? You are at the right place!

|
Team Kalkine

Technical Analysis on One NASDAQ- Listed Biotechnology Stock- JANX

  • Dec 04, 2024
  •   | Read Time : 5 min
Team Kalkine

Technical Analysis on One NYSE- Listed Software Stock- AI

  • Dec 03, 2024
  •   | Read Time : 5 min
Team Kalkine

Technical Analysis on One NYSE- Listed Software Stock- ZETA

  • Dec 02, 2024
  •   | Read Time : 10 Mins
Team Kalkine

Technical Analysis on One ASX-Listed Stock – ILU

  • Dec 02, 2024
  •   | Read Time : 10 Mins
Team Kalkine

One Consumer Stock Can Face Resistance at the Current Levels - LOV

  • Dec 02, 2024
  •   | Read Time : 10 Mins
Team Kalkine

One NYSE- Listed Personal Care Stock at Resistance Level: BBWI

  • Nov 29, 2024
  •   | Read Time : 10 Mins
Team Kalkine

One NYSE- Listed Healthcare Stock at Resistance Level: HIMS

  • Nov 29, 2024
  •   | Read Time : 10 Mins
Team Kalkine

Business Insight on One ASX Listed Insurance Company - NHF

  • Nov 29, 2024
  •   | Read Time : 10 Mins